Achilles Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Achilles Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Achilles Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Achilles Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $50k | 61k | 0.82 |
| 2024-03-31 | $131k | 105k | 1.25 |
| 2023-12-31 | $96k | 109k | 0.89 |
| 2023-09-30 | $52k | 58k | 0.91 |
| 2023-06-30 | $63k | 67k | 0.95 |
| 2023-03-31 | $64k | 67k | 0.96 |
| 2022-12-31 | $23k | 25k | 0.90 |
| 2022-06-30 | $69k | 28k | 2.51 |
| 2022-03-31 | $53k | 18k | 2.94 |
| 2021-12-31 | $283k | 57k | 5.00 |
| 2021-03-31 | $734k | 39k | 18.69 |